What Is Quality by Design in Pharmaceutical Development?UntitledBuilding Quality in, Not Testing It In
Quality by Design Training in Uzbekistan equips pharmaceutical and biopharmaceutical professionals to build quality into products from the earliest stage of development. Quality by Design (QbD) is a systematic, science-based approach in which quality is designed in through a deep understanding of the product and its manufacturing process, rather than tested in at the end. Grounded in the ICH Q8(R2), Q9, Q10 and Q11 guidelines that the FDA and EMA increasingly expect, the programme walks you through the full QbD workflow: the Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), risk assessment, Design of Experiments (DoE), the design space, Process Analytical Technology and the Control Strategy. It suits formulation and analytical scientists, process engineers, quality assurance staff and regulatory affairs specialists in Uzbekistan's fast-growing pharma sector. As domestic manufacturers scale up and export to dozens of markets, QbD skills help you cut deviations, strengthen submissions and move from trial and error to predictable quality. Start your QbD journey with Invensis Learning.










